Read the Latest Study for RELiZORB on Fat Absorption in Patients with CF and EPI Receiving Enteral Nutrition.

Simopoulos A. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy. 2002, 365-379.

Simopoulos A. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomedicine & Pharmacotherapy. 2006; 60: 502-507.

Donaldson, J, Pierzynowski S, et al. The effectiveness of enzymatic replacement therapy measured by turbidimetry and the lipaemic index in exocrine pancreatic insufficient young, growing pigs, fed a high fat diet. Advances in Medical Science. 2009, 7-13.

Jang D, Lindemann M, et al. The effects of fat soluble vitamin administration on plasma vitamin status of nursing pigs. Asian-Australasia Journal of Animal Science. 2014, 674-682.

Peretti N et al. Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency. Nutrition & Metabolism 2005, 2:11.

Bakker M, Bodewes F, et al. Persistent fat malabsorption in cystic fibrosis. Journal of Cystic Fibrosis 2011, 150-158.


This information is intended for
US healthcare professionals


You are now leaving the RELiZORB
product website to view the
Alcresta Therapeutics corporate website.